SCHEMBL7414196

SCHEMBL7414196

CC(=O)c1c(C)n(Cc2ccccc2Cl)c2cc(C(=O)O)ccc12

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.65
SLC22A12 Q96S37 3/20 0.49
PTPN11 Q06124 1/20 0.46
LMNA P02545 2/20 0.45
TSHR P16473 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
TP53 P04637 1/20 0.45
RXFP1 Q9HBX9 1/20 0.45
MAPT P10636 2/20 0.44
POLB P06746 1/20 0.44
NPSR1 Q6W5P4 1/20 0.44
PLA2G2A P14555 1/20 0.44
CCR2 P41597 1/20 0.44
ALOX5AP P20292 1/20 0.43
ALDH1A1 P00352 2/20 0.43
GAA P10253 2/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
PPARG P37231 1/20 0.43
DPP4 P27487 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7428834 0.90 L3MBTL1 (0.64) L3MBTL1SLC22A12LMNATP53RXFP1
SCHEMBL7469713 0.89 L3MBTL1 (0.52) L3MBTL1SLC22A12PTPN11LMNATP53
SCHEMBL7419060 0.89 L3MBTL1 (0.52) L3MBTL1SLC22A12PTPN11LMNASMN1; SMN2
SCHEMBL7421205 0.88 L3MBTL1 (0.62) L3MBTL1LMNATP53MAPTPOLB
SCHEMBL7467256 0.87 L3MBTL1 (0.49) L3MBTL1SLC22A12PTPN11SMN1; SMN2TP53
SCHEMBL150104 0.85 L3MBTL1 (0.47) L3MBTL1SLC22A12PTPN11TP53RXFP1
SCHEMBL7423045 0.84 SLC22A12 (0.49) L3MBTL1SLC22A12PTPN11SMN1; SMN2TP53
SCHEMBL4496691 0.80 PPARG (0.61) L3MBTL1MEN1KMT2APPARG
SCHEMBL7419326 0.80 SLC22A12 (0.45) L3MBTL1SLC22A12PTPN11TP53RXFP1
SCHEMBL7422326 0.79 L3MBTL1 (0.51) L3MBTL1LMNATP53RXFP1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed